ArticleCancer medicine2023

Metastatic sites and lesion numbers cooperated to predict efficacy of PD-1 inhibitor-based combination therapy for patients with metastatic colorectal cancer.

Weiqin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.